Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Jun;24(6):841-6.
doi: 10.1007/s11695-014-1180-7.

Greater weight loss with the omega loop bypass compared to the Roux-en-Y gastric bypass: a comparative study

Affiliations
Comparative Study

Greater weight loss with the omega loop bypass compared to the Roux-en-Y gastric bypass: a comparative study

E Disse et al. Obes Surg. 2014 Jun.

Abstract

Background: Despite similar initial results on weight loss and metabolic control, with a better feasibility than the Roux-en-Y gastric bypass (RYGBP), the omega loop bypass (OLB) remains controversial. The aim of this study was to compare the short-term outcomes of the laparoscopic OLB versus the RYGBP in terms of weight loss, metabolic control, and safety.

Methods: Two groups of consecutive patients who underwent laparoscopic gastric bypass surgery were selected: 20 OLB patients and 61 RYGBP patients. Patients were matched for age, gender, and initial body mass index (BMI). Data concerning weight loss, metabolic outcomes, and complications were collected prospectively.

Results: Mean duration of the surgical procedure was shorter in the OLB group (105 vs. 152 min in the RYGBP group; p < 0.001). Mean excess BMI loss percent (EBL%) at 6 months and at 1 year was greater in the OLB group (76.3 vs. 60.0%, p = 0.001, and 89.0 vs. 71.0%, p = 0.002, respectively). After adjustment for age, sex, initial BMI, and history of previous bariatric surgery, the OLB procedure was still associated with a significantly greater 1-year EBL%. Diabetes improvement at 6 months was similar between both groups. The early and late complication rates were not statistically different. There were three anastomotic ulcers in the OLB group, in smokers, over 60 years old, who were not taking proton pump inhibitor medication.

Conclusions: In this short-term study, we observed a greater weight loss with OLB and similar efficiency on metabolic control compared to RYGBP. Long-term evaluation is necessary to confirm these outcomes.

PubMed Disclaimer

References

    1. Obes Surg. 2010 Dec;20(12):1627-32 - PubMed
    1. Diabetes Care. 2011 Jan;34 Suppl 1:S4-10 - PubMed
    1. Obes Surg. 2008 Jan;18(1):121-8 - PubMed
    1. Obes Surg. 2001 Dec;11(6):773-7 - PubMed
    1. JAMA. 2005 Oct 19;294(15):1909-17 - PubMed

Publication types